These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 9625430

  • 1. Phase II study with cisplatin and paclitaxel in combination with weekly high-dose 24 h infusional 5-fluorouracil/leucovorin for first-line treatment of metastatic breast cancer.
    Klaassen U, Wilke H, Weyhofen R, Harstrick A, Eberhardt W, Müller C, Korn M, Hanske M, Diergarten K, Seeber S.
    Anticancer Drugs; 1998 Mar; 9(3):203-7. PubMed ID: 9625430
    [Abstract] [Full Text] [Related]

  • 2. Infusional 5-fluorouracil/leucovorin plus paclitaxel and cisplatin in the first-line treatment of metastatic breast cancer: results of a phase II study.
    Klaassen U, Wilke H, Müller C, Borquez D, Harstrick A, Seeber S.
    Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-58-S17-60. PubMed ID: 9374095
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U, Wilke H, Seeber S.
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Paclitaxel in combination with weekly 24-hour infusional 5-fluorouracil plus leucovorin in the second-line treatment of metastatic breast cancer: results of a phase II study.
    Klaassen U, Wilke H, Harstrick A, Philippou Pari C, Strumberg D, Neumann K, Eberhardt W, Achterrath W, Lenaz L, Seeber S.
    Ann Oncol; 1998 Jan; 9(1):45-50. PubMed ID: 9541682
    [Abstract] [Full Text] [Related]

  • 7. Phase I/II study with paclitaxel in combination with weekly high-dose 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer: an interim analysis.
    Klaassen U, Wilke H, Pari CP, Strumberg D, Harstrick A, Eberhardt W, Becher R, Diergarten K, Seeber S.
    Semin Oncol; 1995 Dec; 22(6 Suppl 14):7-11. PubMed ID: 8553083
    [Abstract] [Full Text] [Related]

  • 8. Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer.
    Honecker F, Kollmannsberger C, Quietzsch D, Haag C, Schroeder M, Spott C, Hartmann JT, Baronius W, Hempel V, Kanz L, Bokemeyer C.
    Anticancer Drugs; 2002 Jun; 13(5):497-503. PubMed ID: 12045461
    [Abstract] [Full Text] [Related]

  • 9. Preclinical and clinical study results of the combination of paclitaxel and 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer.
    Klaassen U, Harstrick A, Wilke H, Seeber S.
    Semin Oncol; 1996 Feb; 23(1 Suppl 1):44-7. PubMed ID: 8629037
    [Abstract] [Full Text] [Related]

  • 10. A phase I study of weekly docetaxel, 24-hour infusion of high-dose fluorouracil/leucovorin and cisplatin in patients with advanced gastric cancer.
    Chen LT, Liu TW, Wu CW, Chung TR, Shiah HS, Jan CM, Liu JM, Whang-Peng J, Chang JY.
    Oncology; 2002 Feb; 63(3):239-47. PubMed ID: 12381903
    [Abstract] [Full Text] [Related]

  • 11. A weekly 24-h infusion of high-dose 5-fluorouracil (5-FU)+leucovorin and bi-weekly cisplatin (CDDP) was active and well tolerated in patients with non-colon digestive carcinomas.
    Caroli-Bosc FX, Van Laethem JL, Michel P, Gay F, Hendlisz A, Forget F, Bleiberg H.
    Eur J Cancer; 2001 Oct; 37(15):1828-32. PubMed ID: 11576835
    [Abstract] [Full Text] [Related]

  • 12. A phase II study of paclitaxel, weekly, 24-hour continous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer.
    Kollmannsberger C, Quietzsch D, Haag C, Lingenfelser T, Schroeder M, Hartmann JT, Baronius W, Hempel V, Clemens M, Kanz L, Bokemeyer C.
    Br J Cancer; 2000 Aug; 83(4):458-62. PubMed ID: 10945491
    [Abstract] [Full Text] [Related]

  • 13. A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer.
    Lin CC, Cheng AL, Hsu CH, Lu YS, Hsu C, Yeh KH, Wu CY, Huang CS, Yang CH.
    Anticancer Res; 2007 Aug; 27(1B):641-5. PubMed ID: 17348454
    [Abstract] [Full Text] [Related]

  • 14. Phase II trial of weekly paclitaxel, cisplatin plus infusional high dose 5-fluorouracil and leucovorin for metastatic urothelial carcinoma.
    Lin CC, Hsu CH, Huang CY, Cheng AL, Vogelzang NJ, Pu YS.
    J Urol; 2007 Jan; 177(1):84-9; discussion 89. PubMed ID: 17162009
    [Abstract] [Full Text] [Related]

  • 15. Oxaliplatin plus high-dose leucovorin and 5-fluorouracil in pretreated advanced breast cancer: a phase II study.
    Pectasides D, Pectasides M, Farmakis D, Bountouroglou N, Nikolaou M, Koumpou M, Mylonakis N, Kosmas C.
    Ann Oncol; 2003 Apr; 14(4):537-42. PubMed ID: 12649097
    [Abstract] [Full Text] [Related]

  • 16. Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma.
    Chi KH, Chan WK, Shu CH, Law CK, Chen SY, Yen SH, Chen KY.
    Cancer; 1995 Dec 01; 76(11):2186-92. PubMed ID: 8635020
    [Abstract] [Full Text] [Related]

  • 17. Paclitaxel and leucovorin-modulated infusional 5-fluorouracil combination chemotherapy for metastatic gastric cancer.
    Cho BC, Kim JH, Kim CB, Sohn JH, Choi HJ, Lee YC, Ahn JB.
    Oncol Rep; 2006 Mar 01; 15(3):621-7. PubMed ID: 16465422
    [Abstract] [Full Text] [Related]

  • 18. Biweekly low-dose sequential gemcitabine, 5-fluorouracil, leucovorin, and cisplatin (GFP): a highly active novel therapy for metastatic adenocarcinoma of the exocrine pancreas.
    Araneo M, Bruckner HW, Grossbard ML, Frager D, Homel P, Marino J, DeGregorio P, Mortazabi F, Firoozi K, Jindal K, Kozuch P.
    Cancer Invest; 2003 Mar 01; 21(4):489-96. PubMed ID: 14533437
    [Abstract] [Full Text] [Related]

  • 19. Paclitaxel, 5-fluorouracil, and leucovorin (TFL) in the treatment of metastatic breast cancer.
    Nicholson BP, Paul DM, Hande KR, Shyr Y, Meshad M, Cohen A, Johnson DH.
    Clin Breast Cancer; 2000 Jul 01; 1(2):136-43; discussion 144. PubMed ID: 11899652
    [Abstract] [Full Text] [Related]

  • 20. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
    Hsu CH, Cheng AL, Hsu C, Yang CH, Lu YS, Lin CC, Bu CF, Yeh KH.
    Anticancer Res; 2002 Jul 01; 22(6B):3621-7. PubMed ID: 12552966
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.